介素-31向药物和其他用于的新药物
Peter Olah1, Ulrike Raap2, Bernhard Homey1
1Department of Dermatology, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
概括
新型生物疗法向介素-31治疗炎症性皮肤疾病中的慢性. 这篇综述涵盖了炎症性疾病,免疫路径和这种衰弱症状的新疗法.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 慢性严重影响生活质量,并带来管理挑战.
- 对于的传统治疗方法通常具有有限的疗效或低于最佳的安全性.
- 最近的研究已经阐明了神经免疫路径参与.
研究的目的:
- 审查炎症性皮肤疾病,其中是主要负担.
- 讨论导致的免疫路径和感官电路.
- 评估针对慢性的新疗法.
主要方法:
- 关于炎症性皮肤疾病和的文献综述.
- 对感的分子机制的分析.
- 针对介质蛋白-31.1. 的生物疗法的评估.
主要成果:
- 联31是一种关键的细胞因子,在与炎症性皮肤疾病相关的中起作用.
- 针对IL-31的新生物疗法对慢性有前途.
- 了解神经免疫交叉通话对于开发有效治疗方法至关重要.
结论:
- 向介素-31为慢性提供了一个有前途的治疗策略.
- 了解机制的进步正在推动新治疗方法的开发.
- 需要进一步的研究来优化新疗法的疗效和安全性.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
527
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
527
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
465
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
465
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
604
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
604